[Interview booklet] Quality control of cell manufacturing without human intervention through mechanization.
Quality control for cell manufacturing without human intervention: Automation and mechanization are strong allies for venture companies.
At VC Cell Therapy Co., Ltd., we are engaged in the development and practical application of advanced treatments, focusing on outer retinal layer diseases, and are developing technologies and therapies to induce and proliferate retinal cells and RPE cells for medical use using iPS cells. We are also actively introducing automation in quality control, having implemented Sysmex's fully automated immunoassay system aimed at automating cytokine measurement. We spoke with the CTO and members of the research and development department about the realization of automation and mechanization in a venture company dealing with regenerative medicine technology. Excerpt from the interview article: "In the ELISA test, if the concentration of the sample is unknown, multiple samples with different dilution factors must be prepared, but with HISCL, this is not necessary; we can obtain data simply by placing the supernatant directly into the device, which was shocking. Witnessing HISCL produce results in about 20 minutes that would take a whole day with ELISA was truly astonishing." *The full text can be accessed by downloading the user interview article via the "Download Catalog" button. For more details, please feel free to contact us.
Inquire About This Product
basic information
Please contact us.
Price range
Delivery Time
Applications/Examples of results
*You can view the detailed content of the article through the related link. For more information, please feel free to contact us.*
catalog（4）
Download All Catalogs![[Interview booklet] Quality control of cell manufacturing without human intervention through mechanization.](https://image.mono.ipros.com/public/catalog/image/01/b20/796125/IPROS5393216478718667743.jpeg?w=120&h=170)
![[Interview booklet] Achieving cardiac regenerative medicine through rapid protein measurement](https://image.mono.ipros.com/public/catalog/image/01/fe0/791417/IPROS15583398780106859010.jpeg?w=120&h=170)
![[Interview booklet] What measurement devices accelerated research in regenerative medicine technology?](https://image.mono.ipros.com/public/catalog/image/01/750/783646/IPROS3921757335968201992.jpeg?w=120&h=170)
Company information
Since its establishment in 1968, our company has been engaged in the field of specimen testing, focusing on the analysis of samples such as blood and urine, and currently supports the health of people in over 190 countries and regions. In the field of specimen testing, we have achieved a top-class market share in three areas: "Hematology," "Coagulation Testing," and "Urinalysis." We contribute to improving the quality of life (QOL) of people around the world in various scenes of their lifelong healthcare journey, and we aim to realize a rich health society through the optimization of medical care and healthcare costs.